Novartis to gain heart drug in $1.4B deal for Tourmaline Bio

Tourmaline recently unveiled mid-stage trial data for its anti-inflammatory drug, which is ready for Novartis to advance into Phase 3 testing for heart disease.

World Wetlands Day: Oyo advised to curb indiscriminate vegetation clearance – EnviroNews

February 7, 2026

Over four million girls still at risk of female genital mutilation – UN – EnviroNews

February 7, 2026

Source link

Novartis to gain heart drug in $1.4B deal for Tourmaline Bio

World Wetlands Day: Oyo advised to curb indiscriminate vegetation clearance – EnviroNews

Over four million girls still at risk of female genital mutilation – UN – EnviroNews

New study shows that internet networks are growing in Africa, but high phone costs limit accessibility

‘The homeland is in the Pacific’

‘The homeland is in the Pacific’

Leave a Reply Cancel reply

RECOMMENDED NEWS

New algorithms for intelligent and efficient robot navigation among the crowd

Total hints at further Namibia successes

Recreating The World In Their Image

40 Countries Ready To Join BRICS in 2024

POPULAR NEWS

Ghana to build three oil refineries, five petrochemical plants in energy sector overhaul

The world’s top 10 most valuable car brands in 2025

Top 10 African countries with the highest GDP per capita in 2025

Global ranking of Top 5 smartphone brands in Q3, 2024

When Will SHIB Reach $1? Here’s What ChatGPT Says

Novartis to gain heart drug in $1.4B deal for Tourmaline Bio

Related posts

New study shows that internet networks are growing in Africa, but high phone costs limit accessibility

‘The homeland is in the Pacific’

Leave a Reply Cancel reply

RECOMMENDED NEWS

POPULAR NEWS